Jiani Cao
Overview
Explore the profile of Jiani Cao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
442
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhao Y, Cao J, Xu H, Cao W, Cheng C, Tan S, et al.
Cell Prolif
. 2024 Jun;
57(10):e13661.
PMID: 38853761
In vitro T-cell differentiation from pluripotent stem cells (PSCs) could potentially provide an unlimited source of T cells for cancer immunotherapy, which, however is still hindered by the inefficient obtaining...
2.
Niu S, Xia C, Huang D, Wang L, Hu H, Yu S, et al.
Cell Prolif
. 2023 Dec;
57(5):e13588.
PMID: 38124457
'Requirements for Human Natural Killer Cells' is the latest set of guidelines on human NK cells in China, jointly drafted and agreed upon by experts from the Standards Committee of...
3.
Peng Y, Ma A, Xiao Z, Hao J, Feng R, Wang C, et al.
Cell Prolif
. 2023 Oct;
57(3):e13556.
PMID: 37828721
The rapid advancement of human stem cell research and its expansion into emerging areas has resulted in an escalation of ethical challenges associated with these studies. As a result, there...
4.
Wang L, Liu S, Li K, Ma A, Hu C, Wang C, et al.
Cell Prolif
. 2023 Sep;
57(3):e13554.
PMID: 37767639
'General requirements for the production of extracellular vesicles derived from human stem cells' is the first guideline for stem cells derived extracellular vesicles in China, jointly drafted and agreed upon...
5.
Lin H, Wang Y, Cheng C, Qian Y, Hao J, Zhang Z, et al.
Cell Regen
. 2023 Jun;
12(1):24.
PMID: 37378693
Intestinal cancer is one of the most frequent and lethal types of cancer. Modeling intestinal cancer using organoids has emerged in the last decade. Human intestinal cancer organoids are physiologically...
6.
Wang Y, Lin H, Zhao L, Hong F, Hao J, Zhang Z, et al.
Cell Regen
. 2023 Jun;
12(1):23.
PMID: 37314549
Organoids have attracted great interest for disease modelling, drug discovery and development, and tissue growth and homeostasis investigations. However, lack of standards for quality control has become a prominent obstacle...
7.
Cao W, Cao J, Li X, Xu H, Tian J, Li X, et al.
Cell Prolif
. 2023 May;
56(5):e13472.
PMID: 37199017
Haematopoietic stem cell transplantation (HSCT) is widely used in regenerative medicine. HSCT can be used not only to treat certain types of blood cancer and immune disorders but also to...
8.
Cao J, Li M, Liu K, Shi X, Sui N, Yao Y, et al.
Protein Cell
. 2023 May;
14(5):376-381.
PMID: 37155316
No abstract available.
9.
Xu H, Tan S, Zhao Y, Zhang L, Cao W, Li X, et al.
Cell Prolif
. 2023 May;
56(11):e13490.
PMID: 37147872
Despite extensive characterization of the state and function of haematopoietic stem cells (HSCs), the use of transcription factors to define the HSC population is still limited. We show here that...
10.
Bao H, Cao J, Chen M, Chen M, Chen W, Chen X, et al.
Sci China Life Sci
. 2023 Apr;
66(5):893-1066.
PMID: 37076725
Aging biomarkers are a combination of biological parameters to (i) assess age-related changes, (ii) track the physiological aging process, and (iii) predict the transition into a pathological status. Although a...